This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person
Moderna this week started testing a personalized treatment that teaches the body how
to fight cancer.
Pipettes at Moderna labs in Cambridge, Massachusetts on Tuesday, Nov. 14, 2017.
Photographer: Adam Glanzman/BloombergFor Moderna Therapeutics, the road to a cancer breakthrough begins on the back of a FedEx truck.
Six weeks ago, a 1-millimeter cube of cancer tissue collected by doctors from the right lung of 67-year-old retiree Glenda Cleaver was packed in a box at the Sarah Cannon Research Institute in Nashville, Tennessee. It was the beginning of a journey Moderna hopes will lead to a long-sought goal: a vaccine that trains the body to attack tumors.